This study primarily aimed to determine the clinical relevance of YAP1 by examining its association with key clinicopathologic parameters and pathological treatment response and to explore the impact of neoadjuvant chemotherapy on YAP1 expression by comparing its levels in pre- and post-treatment tumor tissues of patients with LABC. Here, YAP1 is linked to neoplasm.